Choose Site

Outside Publication

INSIGHT: FDA Suspends Routine Domestic Drug, Device Inspections Due to Coronavirus, Bloomberg Law

April 03, 2020

Morgan Lewis partners Dennis Gucciardo, Michele Buenafe, and Jacqueline Berman authored a Bloomberg Law Insight regarding the US Food and Drug Administration’s announcement to suspend onsite routine domestic inspections in an effort to slow the spread of the coronavirus (COVID-19). In the article, they discuss the key implications of the suspension.

Read the full Bloomberg Law article >>